Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 301 - 315 of 533 items.
Importation of US-Labelled Rocuronium Bromide Injection distributed by Avir Pharma Inc. Due to Shortage of Canadian-labelled Rocuronium
AlertHealth professional risk communication | 2020-05-25
Importation of Fresenius Propoven 2% due to Shortage of Canadian Labelled Propofol Injection 1% Products
AlertHealth professional risk communication | 2020-05-19
Importation of Spanish-Labelled Salbutamol Aldo-Union inhalers due to Shortage of Canadian-Labelled Salbutamol
AlertHealth professional risk communication | 2020-05-19
Important Safety Information - Importation of Teva UK-labelled Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to Shortage
AlertHealth professional risk communication | 2020-05-13
Unauthorized test kits claiming to diagnose or detect COVID-19 put your health at risk
AlertPublic advisory | 2020-05-07
Importation of US-Labelled Ketamine Hydrochloride for Injection due to Potential Shortage of Canadian-labelled Ketamine
AlertHealth professional risk communication | 2020-05-06
Clinical trial looking at the potential use of convalescent plasma to treat COVID-19
AlertPublic advisory | 2020-05-01
Axid (nizatidine) drug recalled due to presence of NDMA
AlertPublic advisory | 2020-05-01
Importation of US-Labelled Vecuronium Bromide for Injection due to Shortage of Neuromuscular Blocker Products
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled QUELICIN (succinylcholine chloride injection) due to Shortage of Canadian-labelled QUELICIN
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled Rocuronium Bromide Injection Due to Shortage of Canadian-labelled Rocuronium
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled Pancuronium Bromide Injection Due to Shortage of Neuromuscular Blocker Products
AlertHealth professional risk communication | 2020-04-29
Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
AlertInformation update | 2020-04-25
Clinical management support: Known interference between Hemlibra® (emicizumab injection) and lab assays used to diagnose coagulopathy / DIC caused by COVID-19 infection
AlertHealth professional risk communication | 2020-04-17